Log In
Print this Print this

IV tecovirimat (IV TPOXX) (IV ST-246)

  Manage Alerts
Collapse Summary General Information
Company Siga Technologies Inc.
DescriptionIV antiviral compound
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationOrthopox virus
Indication DetailsTreat orthopoxvirus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today